Preference Among Users – Small Molecule Drug Substance
Source: ISR Reports
In Q32021, ISR asked API outsourcers which CDMOs they are currently working with, and if the choice were entirely up to them, which CDMO would they prefer to use for all small molecule drug substance manufacturing. The data show that Cambrex, Patheon, Lonza, STA Pharma and Pfizer CentreOne are each the preferred CDMO among roughly one-third of their current customers. To learn more about CDMO preference among users, follow the link to the Small Molecule API CDMO Benchmarking report preview.
access the Infographic!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
ISR Reports
This website uses cookies to ensure you get the best experience on our website. Learn more